Bronx-Westchester Academy of Physicians
Chapter of NYSAFP
 
 
Awards
Board
Past Courses
dLinks
eJournal
Photos
Newsletter
Hall of Fame
Calendar
Downloads 
Messages
   
NASAT
 
 
 
 
New York Academic Minerva Web Journal
January 2002 Volume 2, Number 01
 
Paper 0201:     
Evaluating the Effectiveness of Acupuncture in the treatment of Chronic Low Back Pain.
Chan, Y. and Xu, X., 
Department of Family Practice and Community Medicine, SVCMC, Jamaica, NY.
BACKGROUND:

Acupuncture is a traditional Chinese medicine, which uses fine needles that are inserted into certain points of the body call ‘acupoints’ to control the ‘vital energy' or ‘qi’.  In 1979, the World Health Organization cited more than 40 conditions for which acupuncture may be indicated.  In November 1997, the National Institute of Health (NIH) provided a limited endorsement for acupuncture in the use of certain types of pain management. Although acupuncture is widely used in many different countries for pain management, it is under utilized here.  This may be due to the fact that acupuncture is not well studied in the United States.
METHODS:
Patients with low back pain were randomly selected from Family Practice Center, Saint Vincent Catholic Medical Center. All patients are evaluated pre and post treatment for any improvement of pain control by acupuncture. Each patient is received 1 to 2 sessions per week, with total of 8 to 10 sessions for the completion of one treatment course. Data will be collected and analyzed at the end of the study for the evaluation of the effectiveness of acupuncture on chronic low back pain.
RESULTS:
 The project is still on going.  However, the preliminary results are encouraging for the use of acupuncture as alternative treatment for low back pain.
CONCLUSION:
Although many people are aware of ‘acupuncture’, there is still overall lack of knowledge about the use of acupuncture for treatment of chronic low back pain.
NYAMWJ 2002, 2:Abstract 0201
Presented to the First BWAFP Research Forum
      
Paper 0202: 

Medication Compliance Among Elderly Patients
De Williams, J. and Enubuzor, H.
Department of Family Practice and Community Medicine, 
SVCMC, Brooklyn, NY

While patients over the age of 65 account for 12% of the general population, they use 30% of prescription medications.  Ambulatory elderly patients take an average of 7.9 drugs per person per day.  In light of these statistics, it is not surprising that there are difficulties with medication compliance, either by overuse (related to forgetfulness or attempts to speed recovery) or underuse (the most common type of non-compliance) which can be linked with memory deficits, drug side effects, or costs.
A confidential survey consisting of 18 questions was conducted for two weeks at the Theodora Jackson Senior Center in Jamaica, Queens. It assessed different factors influencing compliance in following prescribed medications. The participants consisted of men and women older than 65 years old, mainly Hispanics and blacks. Eighty-one survey forms (51 women, 30 men) were compiled and analyzed. Ages ranged from 65 to 83.
The result of this study revealed that the main barriers to medication compliance are: polypharmacy, drug side-effects, cost of medication, lack of proper information, cognitive disfunction (memory deficit is the most common cause of  inappropriate use), and functional disabilities (such as impaired hearing or vision). Several factors interfere with achieving the goal of good compliance when talking about the elderly population. Poor compliance results in inadequate or incomplete treatment, prolonging the course of the disease and the length of therapy, resulting in increasing cost and consequently decreasing compliance. The approach has to be multi-faceted. Multiple strategies are needed to improve medication compliance in elderly patients. Among them are: holding seminars with medical professionals emphasizing clear information, including written instructions to the patients, establishing clear treatment goals, eliminating polypharmacy and simplify dosing regimens, considering the financial resources of the patient, and assisting the patient in organizing a system for taking medications.
 
NYAMWJ 2002, 2:Abstract 0202
Presented to the First BWAFP Research Forum

 

Paper 0203:
Cholesterol and Diabetes, Windows of Opportunity Lost?
Ashita Chandra, MD , Mary Costello, RN, Laura Corsello, MD, and Abraham Hamaoui, MD
SUNY Stony Brook Family Medicine, Stony Brook, NY

OBJECTIVE:
To investigate the proportion of inpatients with diabetes who were screened for cholesterol as a risk factor for heart disease.
DESIGN:
Observational cross-sectional survey study of inpatient charts of diabetic patients..
METHODS:
Seventy sequential charts from our inpatient service of patients were reviewed over a five-week period, during their hospital stay. The patients included in the study were 18 years and older, and had in their problem list the diagnosis of Diabetes Mellitus and did not have specifically any diagnosis stating heart disease.
RESULTS:
On reviewing the inpatient charts of diabetic patients, 24.62% of the charts had cholesterol and risk factors documented, compared to 40% of HbA1c data. This is well below the documentation of hemoglobin and hematocrit (100%) and creatinine (96.92%) values. Hypertension was a secondary diagnosis in 64.61% of this group. Looking at management, ace inhibitors were a part of the management protocol in 40.48% of the diabetic patients with hypertension and in 26.15% of the diabetic patients overall.  Finally, looking at patient education, it was documented in 58.46% of the charts.
CONCLUSIONS:
Primary and secondary preventive programs may need to be incremented further and primary care residents may need to more aggressive in taking the “window of opportunity” when patients are admitted, to reinforce diabetic management and prevention of co-morbid risk factors, given the prevalence of silent cardiovascular disease in that subset of patients.
NYAMWJ 2002, 2:Abstract 0203
Presented to the First BWAFP Research Forum
    
Paper 0204:
Cholesterol Prevention And Awareness In Inpatients
Saul Maslavi, MD, Evelina Tsarik, DO Lilia Gehkman, DO, and Abraham Hamaoui, MD
Department of Family Medicine, Wyckoff Heights Medical Center, Brooklyn, NY

NYAMWJ 2002, 2:Abstract 0204
Presented to the First BWAFP Research Forum
        
Paper 0205:
Awareness of Cholesterol
Abraham Hamaoui, MD, Lisa Miller, and Chuwuma Okoroji, MD
Department of Family Medicine, New York Medical College, Valhalla, NY and St Joseph's Medical Center, Yonkers, NY,
Background.
Atherosclerosis leading to cardiovascular damage begins early in life with the utmost consequences occurring many years later as coronary heart disease and ischemic cerebrovascular disease. For these diseases major advances have been achieved in acute interventional management, but effective primary prevention for the atherosclerosing progression has been mostly elusive, even though information has accumulated heavily in the last decades. Of the many reasons for this, the survey looked to assess the perception of cardiovascular risk by two distinct populations, young and mature adults, and to determine the current awareness of the pathological process by these distinct groups.
Methods
An observational cross-sectional study was undertaken by a survey of patients of a family health center (FHC). The Center is located in Yonkers, NY, and serves mainly an inner-city low-income population. A standardized questionnaire was filled out for each individual before a visit. One hundred and forty participants, 18 years and older, were enrolled sequentially, before their visit. Attrition was less than two percent.
Results.
Looking specifically at cholesterol levels, the results showed that although cholesterol testing and patient education was similar to both populations, awareness of cholesterol values are very much limited in the younger group, where most of the preventive impact should have been achieved.
Conclusions
This project underlines the need for effective primary preventive programs by renovating the message to appeal to a younger audience, if we are to achieve long term reduction in prevalence of cardiovascular disease.
NYAMWJ 2002, 2:Abstract 0205
Presented to the First BWAFP Research Forum


 
 
 
 
 
 
 
  
 

 



+